No Matches Found
No Matches Found
No Matches Found
CareCloud, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape
CareCloud, Inc. has adjusted its valuation, showcasing a P/E ratio of 9, lower than the industry average, and a price-to-book value of 1.73. With a ROCE of 23.41% and ROE of 19.32%, the company demonstrates effective resource management and profitability compared to its peers.
CareCloud's Valuation Upgrade Reflects Strong Financial Performance and Market Position
CareCloud, Inc. has recently experienced a valuation adjustment reflecting a significant change in its financial standing. Key metrics, including a favorable P/E ratio and strong returns on capital and equity, highlight the company's robust market position and consistent growth, with net sales increasing annually and positive financial results over the past four quarters.
Is CareCloud, Inc. overvalued or undervalued?
As of September 19, 2025, CareCloud, Inc. is considered very attractive with a P/E ratio of 9, an EV to EBITDA of 3.32, and a PEG ratio of 0.03, indicating it is undervalued compared to peers and has outperformed the S&P 500 over the past year.
CareCloud, Inc. Experiences Revision in Stock Evaluation Amidst Competitive Market Landscape
CareCloud, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 9 and a price-to-book value of 1.73. With strong profitability metrics, including a ROCE of 23.41% and ROE of 19.32%, the company stands out against riskier competitors, despite experiencing year-to-date volatility.
Is CareCloud, Inc. overvalued or undervalued?
As of September 19, 2025, CareCloud, Inc. is considered very attractive due to its undervaluation, evidenced by a low P/E ratio of 9, an EV to EBITDA of 3.32, a PEG ratio of 0.03, strong ROCE of 23.41%, and ROE of 19.32%, despite a recent stock decline, while its one-year return of 20.69% outpaces the S&P 500's 16.64%.
Is CareCloud, Inc. technically bullish or bearish?
As of September 4, 2025, CareCloud, Inc. shows a bullish technical trend with strong weekly MACD and moving averages, despite a mildly bearish weekly OBV and mixed performance compared to the S&P 500.
Is CareCloud, Inc. overvalued or undervalued?
As of September 11, 2025, CareCloud, Inc. is considered an attractive investment due to its undervalued P/E ratio of 9 compared to the peer average of 12.66, a favorable EV to EBITDA ratio of 3.32, a low PEG ratio of 0.03, strong profitability metrics with a ROCE of 23.41% and ROE of 19.32%, and a 27.08% stock return over the past year, outperforming the S&P 500's 17.14%.
Is CareCloud, Inc. overvalued or undervalued?
As of May 6, 2025, CareCloud, Inc. is considered very attractive and undervalued, with a P/E ratio of 9, an EV to EBITDA of 3.32, and a PEG ratio of 0.03, indicating strong operational efficiency and profitability compared to peers, despite a year-to-date stock decline of 31.97%.
Is CareCloud, Inc. technically bullish or bearish?
As of June 17, 2025, CareCloud, Inc. shows a mildly bullish trend supported by weekly and monthly MACD, KST, and Bollinger Bands, despite some caution from daily moving averages.
Who are in the management team of CareCloud, Inc.?
As of March 2022, the management team of CareCloud, Inc. includes Executive Chairman Mahmud Haq, President A. Hadi Chaudhry, CEO Stephen Snyder, and several directors, including Lawrence Sharnak, Anne Busquet, John Daly, and Cameron Munter. They oversee the company's operations and strategic direction.
What does CareCloud, Inc. do?
CareCloud, Inc. is a healthcare IT company providing cloud-based electronic health records and practice management solutions. As of March 2025, it reported net sales of $28 million and a net profit of $2 million, with a market cap of $101.20 million.
How big is CareCloud, Inc.?
As of Jun 18, CareCloud, Inc. has a market capitalization of 101.20 million, with net sales of 112.51 million and a net profit of 10.04 million over the last four quarters. The balance sheet shows shareholder's funds of 49.77 million and total assets of 71.61 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
